Everyone loses hair, every single day. We see strands everywhere – the shower, in the brush, on our pillows. Thinning in women usually means a reduction in volume as well as less physical hairs on our head. As strands diminish in number, there is a lack of density.
The American Hair Loss Association estimates that women make up roughly 40 percent of Americans experiencing thinning hair and the majority of women will experience some thinning by midlife – putting it right up with weight gain, dry skin and wrinkles.
It is completely natural for hair to thin over time. According to the American Academy of Dermatology, we normally shed about 100 hairs a day. So, while 85-to-95 percent of the hair on your head is growing, the other 5-to-15 percent is in a resting stage. After “resting,” this hair falls out — often while you’re brushing or shampooing it — and is replaced by new growth.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7361651-biota-botanicals-age-related-thinning-hair-care-for-women/
As businesses become increasingly frustrated by shelf-life hardware and out-of-the-box software, hosted solutions have grown increasingly popular, with 81% of corporates already using or planning to use cloud-based services according to recent research.
42% of SMEs who subscribed to hosted services did so in the last 12 months, showing the swift emergence of cloud solutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62395-TalkTalk-business-hosting-solutions
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
TriggerPoint™, the market leader in foam rolling, movement products and education, today announces the launch of the GRID VIBE premium vibrating foam roller. Designed for muscle relaxation and pain reduction, the GRID VIBE pairs TriggerPoint’s patented GRID foam roller design with vibration technology to deliver enhanced muscle mobility experiences.
The GRID VIBE’s vibration frequency is specifically calibrated at 33 hertz for optimal muscle relaxation, minimizing discomfort and allowing users to focus longer on foam rolling tender areas. Research shows that vibration decreases the body’s sensation of pain. When vibration is paired with TriggerPoint’s signature GRID pattern that mimics a massage therapist’s hands, fingers and fingertips, the GRID VIBE effectively targets more layers of tight muscle tissue. The GRID VIBE can be used by anyone for muscle recovery, injury prevention, improving athletic performance, pain management, or boosting overall body movement and mobility.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135751-triggerpoint-grid-vibe-vibrating-foam-roller/
TriggerPoint™, the market leader in foam rolling, movement products and education, today announces the launch of the GRID VIBE premium vibrating foam roller. Designed for muscle relaxation and pain reduction, the GRID VIBE pairs TriggerPoint’s patented GRID foam roller design with vibration technology to deliver enhanced muscle mobility experiences.
The GRID VIBE’s vibration frequency is specifically calibrated at 33 hertz for optimal muscle relaxation, minimizing discomfort and allowing users to focus longer on foam rolling tender areas. Research shows that vibration decreases the body’s sensation of pain. When vibration is paired with TriggerPoint’s signature GRID pattern that mimics a massage therapist’s hands, fingers and fingertips, the GRID VIBE effectively targets more layers of tight muscle tissue. The GRID VIBE can be used by anyone for muscle recovery, injury prevention, improving athletic performance, pain management, or boosting overall body movement and mobility.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135751-triggerpoint-grid-vibe-vibrating-foam-roller/
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
With the start of the holiday season comes the start of party season! Getting glammed up for parties can be tricky and time consuming: thought must be given to everything from how to style your hair and what to wear to how to apply makeup to look fun and festive.
Recognizing an opportunity to create a better world through innovative energy solutions, ENGIE Resources, the third-largest non-residential electricity provider in the United States, has unveiled a new program designed to put more power where it belongs – in the hands of customers.
Called the “Energy Revolution,” the effort seeks to shift the emphasis away from providers’ traditional role, which has been to help customers manage price risk alone, and toward helping customers manage both price and quantity – how much they use, when they use it, and what they pay.
To view the multimedia release go to:
https://www.multivu.com/players/English/8071951-engie-resources-leads-energy-revolution/
